Projet MLCARE (Horizon Europe, appel à projets 2024)
Action : Doctoral Networks
Panel : Information Science and Engineering
Statut du projet : SIGNED

Personalized medicine represents a paradigm shift in healthcare, transitioning from generalized treatment strategies to highly personalized care. This transformation is driven by rapid advancements in digital technologies, which generate massive volumes of data from diverse sources, including genomic sequences, high-resolution imaging, wearable devices, and electronic health records (EHRs). However, despite an annual estimate of 50 petabytes of data generated per hospital, only a fraction is utilized effectively. Harnessing this untapped potential offers a transformative opportunity to uncover novel disease mechanisms and deliver more precise and effective therapeutic interventions.  The MLCARE project seeks to revolutionize personalized medicine by developing cutting-edge AI solutions that integrate genomic, clinical, and environmental data into holistic, multimodal patient representations. Through innovative approaches such as Foundation Models and advanced generative AI methods, MLCARE will address critical challenges in processing complex, high-dimensional, and multimodal datasets. Emphasis will be placed on ensuring the trustworthiness, explainability, and security of AI applications to support real-world clinical decision-making.  A core mission of MLCARE is to train a new generation of interdisciplinary researchers with expertise spanning AI, computational biology, and healthcare. The program will equip doctoral candidates with the technical, analytical, and ethical skills needed to lead the future of patient-centered, AI-driven medicine. By combining state-of-the-art research with a comprehensive training program, MLCARE aims to set new standards in personalized healthcare, ensuring equitable, data-driven solutions that improve outcomes across diverse populations. This project is poised to position Europe at the forefront of global innovation in precision medicine, delivering a timely and impactful response to evolving healthcare challenges.

Mots clés : machine learning, data science, probabilistic data modelling, personalized medicine

Participants :
- Université de Maastricht (Pays-Bas) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Université Louis-et-Maximilien de Munich (Allemagne) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 580544.64 €
- Fundación Progreso y Salud (Espagne) — Partner, beneficiary, Recherche, subvention : 282188.16 €
- Université de Tartu (Estonie) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 278001.72 €
- AstraZeneca (United Kingdom) (Royaume-Uni) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 348738.12 €
- Pixelgen technologies ab (Suède) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Pharmatics limited (Royaume-Uni) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 348738.12 €
- Novo Nordisk (Denmark) (Danemark) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Evidence-based behavior, sl (Espagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Fundacion para la investigacion biomedica del hospital gregorio maranon (Espagne) — Partner, associated partner, Autres, subvention : 0.0 €
- École polytechnique fédérale de Zurich (Suisse) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Université de Séville (Espagne) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Université d'Oxford (Royaume-Uni) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Société Max-Planck pour le développement des sciences (Allemagne) — Partner, beneficiary, Recherche, subvention : 290272.32 €
- Université Paris Cité (France) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 314669.16 €
- Siemens Healthcare (Germany) (Allemagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Hmnc holding gmbh (Allemagne) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 290272.32 €
- Astrazeneca farmaceutica spain, s.a (Espagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Institut Pasteur (France) — Partner, associated partner, Recherche, subvention : 0.0 €
- Université de Copenhague (Danemark) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 335890.08 €
- Université Charles-III de Madrid (Espagne) — Coordinator, beneficiary, Enseignement supérieur ou secondaire, subvention : 564376.32 €
- Université de Liège (Belgique) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 288540.0 €